What is the recommended treatment for whooping cough (pertussis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Whooping Cough (Pertussis)

Azithromycin is the first-line antibiotic for treating pertussis across all age groups, with a 5-day course being as effective as 14 days of erythromycin while causing significantly fewer gastrointestinal side effects. 1

First-Line Treatment Regimen

Azithromycin Dosing by Age

  • Infants <1 month: 10 mg/kg per day for 5 days 1

    • Azithromycin is specifically preferred in this age group due to significantly lower risk of infantile hypertrophic pyloric stenosis (IHPS) compared to erythromycin 1
  • Infants 1-5 months: 10 mg/kg per day for 5 days 1

  • Infants ≥6 months and children: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg per day (maximum 250 mg) on days 2-5 1

  • Adults: 500 mg on day 1, followed by 250 mg per day on days 2-5 1

Key Administration Points

  • Do not administer azithromycin simultaneously with aluminum- or magnesium-containing antacids as they reduce absorption 1
  • Isolate the patient at home and away from work/school for 5 days after starting antibiotics to prevent transmission 1

Alternative Treatment Options

Clarithromycin

  • Infants 1-5 months: 15 mg/kg per day divided into two doses for 7 days 2
  • Children and adults: 7.5 mg/kg (or 500 mg) twice daily for 7 days 3
  • Clarithromycin is equally effective as azithromycin and erythromycin for microbiological eradication 1

Trimethoprim-Sulfamethoxazole (TMP-SMZ)

  • Reserved for patients >2 months of age with macrolide contraindications 1
  • Serves as an effective alternative for patients who cannot tolerate macrolides 4

Erythromycin (Use with Caution)

  • Avoid in infants <1 month due to association with IHPS 1
  • If erythromycin must be used: 40-50 mg/kg/day in children (divided doses) or 1-2 g per day in adults for 14 days 1, 5
  • Erythromycin resistance remains rare (<1%) 1

Timing of Treatment: Critical for Effectiveness

Early Treatment (Catarrhal Phase - First 2 Weeks)

  • Start antibiotics immediately upon clinical suspicion without waiting for culture confirmation 1
  • Early treatment rapidly clears B. pertussis from the nasopharynx, decreases coughing paroxysms, and reduces complications 1
  • This is the only phase where antibiotics can modify disease severity 6

Late Treatment (Paroxysmal Phase - >3 Weeks)

  • Antibiotics have limited clinical benefit on symptoms but remain indicated to prevent transmission 1
  • Approximately 80-90% of untreated patients spontaneously clear B. pertussis within 3-4 weeks from cough onset 1

Comparative Efficacy Evidence

  • A large multicenter randomized trial demonstrated 100% bacterial eradication with both azithromycin (5 days) and erythromycin (10 days), with no bacterial recurrence in either group 7
  • Gastrointestinal adverse events occurred in only 18.8% of azithromycin recipients versus 41.2% of erythromycin recipients 7
  • Compliance was markedly superior with azithromycin: 90% took 100% of prescribed doses versus only 55% with erythromycin 7

Therapies That Do NOT Work

  • Do not use long-acting β-agonists, antihistamines, corticosteroids, or pertussis immunoglobulin—these have no proven benefit in controlling coughing paroxysms 1

Postexposure Prophylaxis for Close Contacts

Who Requires Prophylaxis

  • All household contacts regardless of age or vaccination status 2, 3
  • High-priority groups: Infants <12 months (especially <4 months) and women in third trimester of pregnancy 1, 3
  • Healthcare workers with known exposure should receive prophylaxis or be monitored daily for 21 days 3

Prophylaxis Regimen

  • Use the same antimicrobial agents and dosing regimens as treatment 1, 2
  • Administer within 21 days of exposure for effectiveness 3
  • Goal is to eradicate B. pertussis from the nasopharynx of infected persons (symptomatic or asymptomatic) and create a protective "cocoon" around vulnerable infants 2, 3

Important Caveats and Pitfalls

  • Pertussis is highly infectious with secondary attack rates exceeding 80% among susceptible household contacts 3
  • Patients are most infectious during the catarrhal stage and first 3 weeks after cough onset 3
  • Antibiotic prophylaxis does not provide long-term protection; vaccination remains the most important preventive strategy 3
  • Vaccine immunity wanes after 5-10 years, making previously vaccinated adolescents and adults susceptible 3
  • Macrolides (erythromycin and clarithromycin, but NOT azithromycin) inhibit cytochrome P450 enzymes and can interact with other medications (digoxin, triazolam, ergot alkaloids) 1

References

Guideline

Treatment of Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prophylactic Antibiotics for Infants with Parents Exposed to Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Exposure Prophylaxis for Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotics for whooping cough (pertussis).

The Cochrane database of systematic reviews, 2005

Research

Pertussis: a reemerging infection.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.